Optimising artificial intelligence in the pharmaceutical industry 7wData

Artificial intelligence (AI) has wide-reaching potential within the pharmaceutical industry, from clinical trials to marketing and sales analytics. Using a machine learning programme can reduce the time spent on examining data, saving money and allowing researchers to focus on other issues. European Pharmaceutical Review's Victoria Rees spoke with Christopher Rafter, Chief Operating Officer (COO) of Inzata Analytics, to discover more about AI in pharma and its capabilities. As a machine learning system, AI allows researchers to collect and analyse data effectively, Rafter explained. He described the basic principle; the more data it analyses, the more it will improve.